Prosecution Insights
Prosecution Insights
9 pending office actions • 6 art units • 8 examiners • 0 of 9 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (11%) |
| §102 only | 1 (11%) |
| §112 only | 1 (11%) |
| Double-patenting only | 1 (11%) |
| Multi-statute (no §101) | 4 (44%) |
| No statute on record | 1 (11%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OH, TAYLOR V | 2 | 81.2% | +15.3% |
| KOSAR, ANDREW D | 1 | 41.4% | +31.8% |
| MOORE, SUSANNA | 1 | 67.9% | +31.6% |
| CHAO, ALLEN | 1 | 66.7% | +0.0% |
| ALLEN, MICHAEL D | 1 | 32.4% | +49.2% |
| RONEY, CELESTE A | 1 | 62.8% | +17.7% |
| HOEKSTRA, JEFFREY GERBEN | 1 | 55.7% | +39.6% |
| KAUFMAN, CLAIRE M | 1 | 63.3% | +51.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18693319 | SPIROHETEROCYCLE DERIVATIVE HAVING SEROTONIN RECEPTOR BINDING ACTIVITY | OH, TAYLOR V | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278876 | METHOD FOR DETECTING AND QUANTIFYING NUCLEIC ACID FROM ENVIRONMENTAL SAMPLES | ALLEN, MICHAEL D | 2d overdue |
| 18014097 | COMBINED USE OF ANTI-CCR8 ANTIBODY AND CHEMOTHERAPEUTIC AGENT | KAUFMAN, CLAIRE M | 30d |
| 18729630 | PHARMACEUTICAL FOR TREATMENT OF NOVEL CORONAVIRUS INFECTION | OH, TAYLOR V | — |
| 18684486 | NUCLEOSIDE DERIVATIVES AND PRODRUGS THEREOF HAVING VIRAL GROWTH INHIBITORY ACTION | CHAO, ALLEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18024459 | LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT | RONEY, CELESTE A | 5d overdue |
| 18278876 | METHOD FOR DETECTING AND QUANTIFYING NUCLEIC ACID FROM ENVIRONMENTAL SAMPLES | ALLEN, MICHAEL D | 2d overdue |
| 18014097 | COMBINED USE OF ANTI-CCR8 ANTIBODY AND CHEMOTHERAPEUTIC AGENT | KAUFMAN, CLAIRE M | 30d |
| 18578932 | NITROGEN-CONTAINING TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF | KOSAR, ANDREW D | 84d |
| 18729630 | PHARMACEUTICAL FOR TREATMENT OF NOVEL CORONAVIRUS INFECTION | OH, TAYLOR V | — |
| 18755191 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE | MOORE, SUSANNA | — |
| 18693319 | SPIROHETEROCYCLE DERIVATIVE HAVING SEROTONIN RECEPTOR BINDING ACTIVITY | OH, TAYLOR V | — |
| 18171844 | SIGNAL PROCESSING APPARATUS, AND SIGNAL PROCESSING METHOD | HOEKSTRA, JEFFREY GERBEN | — |
| Art Unit | Apps |
|---|---|
| 1625 | 2 |
| 1622 | 1 |
| 1671 | 1 |
| 1612 | 1 |
| 3791 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18578932 | NITROGEN-CONTAINING TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF | KOSAR, ANDREW D | 1625 | — | Final Rejection | 84d | Pending | Aug 22, 2024 |
| 18729630 | PHARMACEUTICAL FOR TREATMENT OF NOVEL CORONAVIRUS INFECTION | OH, TAYLOR V | — | §102§103§112 | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18755191 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE | MOORE, SUSANNA | — | DP | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18693319 | SPIROHETEROCYCLE DERIVATIVE HAVING SEROTONIN RECEPTOR BINDING ACTIVITY | OH, TAYLOR V | 1625 | §112 | Non-Final OA | — | Pending | Mar 19, 2024 |
| 18684486 | NUCLEOSIDE DERIVATIVES AND PRODRUGS THEREOF HAVING VIRAL GROWTH INHIBITORY ACTION | CHAO, ALLEN | 1622 | §102§103 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18278876 | METHOD FOR DETECTING AND QUANTIFYING NUCLEIC ACID FROM ENVIRONMENTAL SAMPLES | ALLEN, MICHAEL D | 1671 | §102§103§112 | Non-Final OA | 2d overdue | Pending | Aug 25, 2023 |
| 18024459 | LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT | RONEY, CELESTE A | 1612 | §103 | Non-Final OA | 5d overdue | Pending | Mar 02, 2023 |
| 18171844 | SIGNAL PROCESSING APPARATUS, AND SIGNAL PROCESSING METHOD | HOEKSTRA, JEFFREY GERBEN | 3791 | §102 | Non-Final OA | — | Pending | Feb 21, 2023 |
| 18014097 | COMBINED USE OF ANTI-CCR8 ANTIBODY AND CHEMOTHERAPEUTIC AGENT | KAUFMAN, CLAIRE M | 1674 | §102§112Other | Non-Final OA | 30d | Pending | Dec 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial